CLINICAL IMPACT OF METRONOMIC ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER

被引：0
|
作者：
Fujihara, Miwa [1 ]
Ohtani, Shoichiro [1 ]
Ito, Mistuya [1 ]
Kajiwara, Yukiko [1 ]
Yoshimura, Yuri [1 ]
机构：
[1] Hiroshima City Hiroshima Citizens Hosp, Breast Surg, Naka Ku, Hiroshima, Japan
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)30065-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO53
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] METRONOMIC ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER: A SINGLE INSTITUTION EXPERIENCE
    Takao, Shintaro
    Tane, Kaori
    Hirokaga, Kouichi
    Maekawa, Youko
    BREAST, 2011, 20 : S47 - S47
  • [2] Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide in patients with HER2-negative metastatic breast cancer
    Ohtani, S.
    Fujihara, M.
    ANNALS OF ONCOLOGY, 2015, 26 : 30 - 30
  • [3] CLINICAL AND BIOLOGICAL ACTIVITY OF METRONOMIC CAPECITABINE AND CYCLOPHOSPHAMIDE IN COMBINATION WITH BEVACIZUMAB IN METASTATIC BREAST CANCER
    Dellapasqua, S.
    Bertolini, F.
    Bagnardi, V.
    Campagnoli, E.
    Scarano, E.
    Torrisi, R.
    Shaked, Y.
    Mancuso, P.
    Goldhirsch, A.
    Colleoni, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 66 - 67
  • [4] Metronomic chemotherapy with capecitabine and oral cyclophosphamide in combination with bevacizumab in metastatic breast cancer (mbc): Evidence of activity of an antiangiogenic treatment
    Rocca, A.
    Dellapasqua, S.
    Pietri, E.
    Dettori, M.
    D'Alessandro, C.
    Ghisini, R.
    Colombo, A.
    Goldhirsch, A.
    Colleoni, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer
    Masataka Yoshimoto
    Shintaro Takao
    Masaru Hirata
    Yasushi Okamoto
    Sumio Yamashita
    Yoshihiro Kawaguchi
    Makoto Takami
    Hidemi Furusawa
    Satoshi Morita
    Chigusa Abe
    Junichi Sakamoto
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 331 - 338
  • [6] Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer
    Yoshimoto, Masataka
    Takao, Shintaro
    Hirata, Masaru
    Okamoto, Yasushi
    Yamashita, Sumio
    Kawaguchi, Yoshihiro
    Takami, Makoto
    Furusawa, Hidemi
    Morita, Satoshi
    Abe, Chigusa
    Sakamoto, Junichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (02) : 331 - 338
  • [7] Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study
    Tanaka, Maki
    Takamatsu, Yasushi
    Anan, Keisei
    Ohno, Shinji
    Nishimura, Reiki
    Yamamoto, Yutaka
    Masuda, Norikazu
    Mitsuyama, Shoshu
    Tamura, Kazuo
    ANTI-CANCER DRUGS, 2010, 21 (04) : 453 - 458
  • [8] ALL-ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IS EFFECTIVE AND SAFE FOR METASTATIC BREAST CANCER PATIENTS
    Suzuki, Masahiko
    BREAST, 2013, 22 : S42 - S42
  • [9] Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: phase II study.
    Tanaka, M.
    Tamura, K.
    Anan, K.
    Ohno, S.
    Nishimura, R.
    Yamamoto, Y.
    Masuda, N.
    Mitsuyama, S.
    CANCER RESEARCH, 2009, 69 (02) : 383S - 384S
  • [10] The combination of capecitabine and cyclophosphamide for metastatic breast cancer patients
    Suzuki, M.
    Kimijima, I.
    Ishii, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345